Capital Advisors Inc. OK Sells 127 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Capital Advisors Inc. OK cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 10.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,045 shares of the company’s stock after selling 127 shares during the quarter. Capital Advisors Inc. OK’s holdings in HCA Healthcare were worth $314,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. FMR LLC lifted its stake in shares of HCA Healthcare by 322.3% in the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after acquiring an additional 2,397,883 shares during the last quarter. Meritage Group LP bought a new position in HCA Healthcare in the third quarter valued at about $150,548,000. Canoe Financial LP grew its holdings in shares of HCA Healthcare by 226,952.9% during the fourth quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock worth $69,513,000 after purchasing an additional 231,492 shares during the last quarter. Holocene Advisors LP boosted its position in HCA Healthcare by 210.6% during the 3rd quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock worth $124,691,000 after buying an additional 208,015 shares during the period. Finally, Nordea Investment Management AB increased its position in HCA Healthcare by 29.7% in the 4th quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock valued at $253,020,000 after acquiring an additional 193,075 shares during the period. Institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the company. Bank of America decreased their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a report on Monday, January 27th. Royal Bank of Canada cut their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research note on Monday, January 27th. Wells Fargo & Company lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their price target for the stock from $400.00 to $320.00 in a report on Monday, November 25th. Truist Financial decreased their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, TD Cowen decreased their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Stock Performance

NYSE HCA opened at $312.55 on Thursday. The company has a market cap of $79.17 billion, a P/E ratio of 14.23, a PEG ratio of 1.11 and a beta of 1.64. The company has a fifty day simple moving average of $313.49 and a 200 day simple moving average of $353.04. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the prior year, the company earned $5.90 earnings per share. Sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a dividend of $0.72 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.92%. The ex-dividend date is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is 12.02%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.